March 29th 2024
Andre Goy, MD, discusses the implementation of CAR T-cell therapy in patients with relapsed/refractory mantle cell lymphoma.
December 5th 2023
Andre Goy, MD, discusses the prevalence of high-risk clinical features in patients with mantle cell lymphoma and their influence on treatment approaches.
March 14th 2023
Andre H. Goy, MD, discusses the appropriate monitoring and management of patients with mantle cell lymphoma who display genetic abnormalities but are not considered to be high risk.
March 13th 2023
Andre H. Goy, MD, discusses differentiating between disease presentations in mantle cell lymphoma.
September 15th 2022
Andre H. Goy, MD, discusses updates in precision medicine.
September 20th 2021
Andre H. Goy, MD, discusses the importance of refined decision making with precision medicine.
May 6th 2021
Andre H. Goy, MD, discusses the durability of response with brexucabtagene autoleucel in mantle cell lymphoma.
April 19th 2021
Andre H. Goy, MD, discusses the potential utility of lisocabtagene maraleucel in mantle cell lymphoma.
April 8th 2021
Andre Goy, MD, discusses the clinical implications of CAR T-cell therapy in mantle cell lymphoma.
March 12th 2021
Andre Goy, MD, discusses the next steps with CAR T-cell therapy in mantle cell lymphoma.
September 26th 2020
Andre Goy, MD, MS, discusses updates in precision medicine.
July 17th 2020